Sound Pharmaceuticals to launch NIH-funded Covid-19 oral therapeutic trial,

Sound Pharmaceuticals is all set to launch two Phase II clinical trials of an oral capsule, SPI-1005, for treating patients with moderate or severe …, Sound Pharmaceuticals is all set to launch two Phase II clinical trials of an oral capsule, SPI-1005, for treating patients with moderate or severe …, Read More

Scroll to Top